Funda Taşlı

Funda Taşlı

Auto-generated profile, based on publicly available information

Funda Taşlı

Department of Pathology, İzmir City Hospital, İzmir, Türkiye

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in The Korean Journal of Pathology
Verified
Journal Article
Open access
PDF file
GÖGüliz Özkök
Güliz Özkök
FTFunda Taşlı
Funda Taşlı
NÖNazan Özsan
Nazan Özsan
RÖRafet Öztürk
Rafet Öztürk
HPHakan Postacı
Hakan Postacı
Özkök G, et al. Korean J Pathol. 2013 Dec;47(6):579-582. http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.579

1 October 2022 in European Journal of Breast Health
Verified
Journal Article
Closed access
BZBaha Zengel
Baha Zengel
DÇDemet Çavdar
Demet Çavdar
ÖÖÖzlem Özdemir
Özlem Özdemir
FTFunda Taşlı
Funda Taşlı
MKMurat Karatas
Murat Karatas
AUAdam Uslu
Adam Uslu
Invasive lobular carcinoma (ILC) accounts for almost 15% of all breast carcinomas. The potential of ILC to metastasize to the gastointestinal system is significantly greater than that of invasive ductal carcinoma. Gastric metastasis occurred in the ninth year of the follow-up in a patient who was operated on the right breast due to ILC. The patient was investigated for simultaneous masses in the stomach and colon, and a random mass was found in her right breast.

6 August 2014 in APMIS
Verified
Journal Article
Closed access
PDF file
FTFunda Taşli
Funda Taşli
GÖGüliz Özkök
Güliz Özkök
AAAsuman Argon
Asuman Argon
DEDidem Ersöz
Didem Ersöz
AYAyşe Yağci
Ayşe Yağci
EVEnver Vardar
Enver Vardar

8 January 2021 in Medicine
Verified
Journal Article
Open access
MKMurat Karatas
Murat Karatas
BZBaha Zengel
Baha Zengel
RDRaika Durusoy
Raika Durusoy
FTFunda Tasli
Funda Tasli
ZAZehra Adibelli
Zehra Adibelli
AUAdam Uslu
Adam Uslu
The most common site for metastasis in patients with breast cancer is the bone. In this case series, we investigated patients whose surgical and medical treatment for primary breast cancer was conducted at our center and first disease recurrence was limited to only 1 bone. We analyzed 910 breast cancer patients, 863 had no metastasis and 47 cases had a single bone metastasis ≥ 6 months after their first diagnosis. Demographic, epidemiological, histopathological and intrinsic tumor subtype differences between the non-metastatic group and the group with solitary bone metastases and their statistical significance were examined. Among established breast cancer risk factors, we studied twenty-nine variables. Three variables (Type of tumor surgery, TNM Stage III tumors and mixed type (invasive ductalcarsinoma + invasive lobular carcinoma) histology) were significant in multivariate logistic regression analysis. Accordingly, the risk of developing single bone metastasis was approximately 15 times higher in patients who underwent mastectomy and 4.8 and 2.8 times higher in those with TNM Stage III tumors and with mixed type (invasive ductal carcinoma + invasive lobular carcinoma) histology, respectively. In conclusion, the risk of developing single bone metastasis is likely in non-metastatic patients with Stage III tumors and possibly in mixed type tumors. Knowing this risk, especially in patients with mixed type tumors, may be instrumental in taking measures with different adjuvant therapies in future studies. Among these, treatment modalities such as prolonged hormone therapy and addition of bisphosphonates to the adjuvant treatments of stage III and mixed breast cancer patients may be considered.

1 January 2021 in SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital
Verified
Journal Article
Open access
ÖÖÖzlem Özdemir
Özlem Özdemir
BZBaha Zengel
Baha Zengel
YYYasar Yildiz
Yasar Yildiz
SSSERAY SARAY
SERAY SARAY
AAAhmet Alacacioglu
Ahmet Alacacioglu
YKYuksel Kucukzeybek
Yuksel Kucukzeybek
The Medical Bulletin of Sisli Etfal Hospital

19 July 2013 in Renal Failure
Verified
Journal Article
Closed access
FTFunda Taşlı
Funda Taşlı
GÖGüliz Özkök
Güliz Özkök
EOEbru Sevinç Ok
Ebru Sevinç Ok
NSNur Soyer
Nur Soyer
HMHülya Mollamehmetoğlu
Hülya Mollamehmetoğlu
EVEnver Vardar
Enver Vardar
Primary hyperoxaluria is a rare autosomal recessive disorder. Type 1 PH is the most common form and develops due to a defect in a liver specific enzyme the alanine aminotransferase enzyme. As a result of the enzyme deficiency, there is an overproduction of oxalate and excessive urinary excretion. Recurrent urolithiasis and nephrocalcinosis are the most important findings of the disorder and often at the beginning end-stage renal disease develops. This report presents a case backed up by literature of a patient with end stage renal failure and erythropoietin-resistant anaemia whose bone marrow biopsy showed crystal deposition which received delayed diagnosis of oxalosis.